Compare IDXX & FMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDXX | FMX |
|---|---|---|
| Founded | 1983 | 1890 |
| Country | United States | Mexico |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.1B | 38.1B |
| IPO Year | 1996 | 1998 |
| Metric | IDXX | FMX |
|---|---|---|
| Price | $575.10 | $101.48 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $715.00 | $108.83 |
| AVG Volume (30 Days) | ★ 432.6K | 329.5K |
| Earning Date | 04-30-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 6.68% |
| EPS Growth | ★ 22.59 | N/A |
| EPS | ★ 13.08 | N/A |
| Revenue | ★ $4,303,702,000.00 | N/A |
| Revenue This Year | $10.88 | $10.25 |
| Revenue Next Year | $8.59 | $8.35 |
| P/E Ratio | $44.36 | ★ $40.94 |
| Revenue Growth | ★ 10.42 | N/A |
| 52 Week Low | $356.25 | $83.08 |
| 52 Week High | $769.98 | $116.09 |
| Indicator | IDXX | FMX |
|---|---|---|
| Relative Strength Index (RSI) | 33.64 | 32.32 |
| Support Level | $567.62 | $99.20 |
| Resistance Level | $657.26 | $106.48 |
| Average True Range (ATR) | 16.66 | 2.74 |
| MACD | -2.23 | -0.87 |
| Stochastic Oscillator | 8.96 | 4.43 |
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.
Mexico-based Femsa is a beverage and retail conglomerate in Central and South America. The holding company owns controlling stakes in bottler Coca-Cola Femsa (47% economic stake, 56% voting rights), in addition to operating 100%-owned retail assets, including convenience stores under the Oxxo banner, drugstores, and gas stations. The firm divested its 15% stake in Heineken and its distribution business in 2023. Coca-Cola Femsa and the Oxxo chain made up 75% of total company revenue and over 90% of profits in 2024.